Jim Post

Jim Post has a diverse work experience in the healthcare industry. Jim currently holds the position of CEO at ALCOR Scientific and is a Member of the Board of Directors at Dreampath Diagnostics. Prior to these roles, they worked as an Executive Advisor at Water Street Healthcare Partners. Jim has also served as President and CEO at Epredia, President at Thermo Fisher Scientific, and VP of Commercial Operations at Thermo Fisher Scientific's Anatomical Pathology Division. Before that, they were the Executive VP of Commercial Operations at Cepheid. Jim's earlier experiences include being the Global President Acute Care at Alere Inc., Vice President of Sales and Marketing at Biosite, and Vice President of Sales at US Surgical. Throughout their career, they have demonstrated strong leadership skills, successfully managed multiple teams, and played a key role in mergers and acquisitions activities.

Jim Post has pursued their education at the University of Rochester. Jim first obtained a Certification in Business Management Allied Field. Later, they completed a Bachelor of Arts (B.A.) degree with a major in Psychology and Sociology. No specific start or end years were provided for either of these educational experiences.